Patents expiring in 2029

US 7537759

Modulating angiogenesis

The Regents of the University of California · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7537923

Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538136

Crystalline forms of atorvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538189

Methods of making deuterated cyclosporin analogs

Isotechnika, Inc. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538133

Benzimidazole derivatives, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538097

Inhibition of antigen presentation with poorly catabolized polymers

HALOZYME, INC. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538129

Diazonamide A analog

The Board of Regents of the University of Texas System · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538183

HPV vaccine comprising peptides from host cell proteins

University College Cardiff Consultants Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7538125

Pharmaceutical composition

Takeda Pharmaceutical Company Limited · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541035

Immunogenic peptides for the treatment of prostate and breast cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541331

Surfactant treatment regimen

Discovery Laboratories, Inc. · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541463

Sulfur-containing naphthalimide derivatives

East China University of Science and Technology · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541429

Comparative ligand mapping from MHC positive cells

The Board of Regents of the University of Oklahoma · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541478

Coumarin derivative and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541381

Non-covalent inhibitors of AmpC β-lactamase

Northwestern University · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541346

Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7541040

Chimeric molecule for the treatment of th2-like cytokine mediated disorders

The United States of America as represented by the Department of Health and Human Serivces · Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544486

Nell peptide expression systems and bone formation activity of nell peptide

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544670

HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544481

Nucleic acids encoding CD40 binding protein

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544358

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544661

Self-assembling peptide amphiphiles and related methods for growth factor delivery

Northwestern University · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544499

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

HALOZYME, INC. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544738

Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

Nektar Therapeutics AL, Corporation · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544789

DNA encoding Toxoplasma gondii rDGP5p protein

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544713

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544364

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547712

Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547787

Processes for preparing montelukast sodium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547698

Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

Xenon Pharmaceuticals Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547726

AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547546

Progenitor cells from wharton's jelly of human umbilical cord

Tissue Regeneration Therapeutics Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547509

Cyanovirin variant-polymer conjugates

Nektar Therapeutics AL, Corporation · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547759

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547794

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547773

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547806

Tannate salt of rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547762

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547716

Sulfonamide derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547686

Combretastatin A-3 prodrug

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550598

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550590

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550005

Coated implantable medical device

Cook Regentec LLC · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)